Tropomyosin autoantibodies associated with checkpoint inhibitor myositis

Pauline Zaenker, David Prentice, Melanie Ziman

Research output: Contribution to journalArticle


This brief report details the measurement and identification of IgA antibodies to tropomyosin in a case of presumed ocular myositis with paraspinal myositis in a patient with metastatic uveal melanoma treated with checkpoint inhibitors. High-throughput functional protein microarray analysis and pathway analysis was conducted to identify IgG and IgA antibodies of interest. Antibody levels were compared to generic antibody screening results and levels of the antibodies in a cohort of melanoma patients without myositis (n = 100) at baseline prior to undergoing immunotherapy. The finding of specific muscle antibodies in this clinical case indicates the pathogenic potential of anti-tropomyosin IgA in the development of checkpoint inhibitor associated myositis and requires further investigation.

Original languageEnglish
Article number1804703
Issue number1
Publication statusPublished - 1 Jan 2020

Fingerprint Dive into the research topics of 'Tropomyosin autoantibodies associated with checkpoint inhibitor myositis'. Together they form a unique fingerprint.

Cite this